-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, F4PTXqN7I9gfrIcAoO+pa0SwfDc1PR9ODOzXPh1wlQoj4mRTxTr5fCnTtqa4Tdou aVo96zjFIyaMmvEsvW7q4w== 0001179110-05-008138.txt : 20050426 0001179110-05-008138.hdr.sgml : 20050426 20050426110852 ACCESSION NUMBER: 0001179110-05-008138 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040124 FILED AS OF DATE: 20050426 DATE AS OF CHANGE: 20050426 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 787 SEVENTH AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125544555 MAIL ADDRESS: STREET 1: 787 SEVENTH AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GIMBERT JOAN PONS CENTRAL INDEX KEY: 0001221445 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27282 FILM NUMBER: 05771916 MAIL ADDRESS: STREET 1: JOSEP SAMITHER 15 STREET 2: BORCLONA SCIENCE PARK CITY: BORCELONA SPAIN STATE: U3 ZIP: 0000 4 1 edgar.xml FORM 4 - X0202 4 2004-01-24 0 0001001316 MANHATTAN PHARMACEUTICALS INC MHTT 0001221445 GIMBERT JOAN PONS C/O OLEOYL-ESTRONE DEVELOPEMENTS, SL JOSEP SAMITIER 1-5 SCIENCE PARK BARCELONA U3 U3 08028 SPAIN 1 0 0 0 Common Stock 3957037 I By Oleoyl-Estrone Developments SL Option 1.65 2004-01-24 4 A 0 75000 0 A 2014-01-27 Common Stock 75000 75000 D Director Stock Option 1 2005-01-11 4 A 0 25000 0 A 2015-01-11 Common Stock 25000 25000 D The Reporting Person is the chief executive officer of Oleoyl-Estrone Developments SL, a company of unlimited duration registered in the Registro Mercantil of Carcelona ("OED"). The Reporting Person disclaims beneficial Ownership of the shares owned by OED. 25,000 shares have vested. 25,000 shares vest, if at all, on 1/28/05 and 1/28/06, respectively. Under the 2003 Stock Option Plan. 8,334 shares vest on 1/11/05, 8,333 shares vest on each of 1/11/06 and 1/11/07. /s/ Joan Pons Gimbert 2005-04-26 -----END PRIVACY-ENHANCED MESSAGE-----